A Randomized, Placebo Controlled, Multicenter Phase 2 Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 02 May 2018
At a glance
- Drugs Propranolol/etodolac (Primary)
- Indications Cachexia
- Focus Therapeutic Use
- Sponsors Vicus Therapeutics
- 31 Aug 2018 Biomarkers information updated
- 24 Apr 2018 Status changed from active, no longer recruiting to discontinued.
- 08 Dec 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Apr 2016 as reported by ClinicalTrials.gov.